Telefonica Czech Republic A.S. GDR (TFATF) Financials Nov
Telefonica Czech Republic A.S. GDR (TFATF) Financials Nov 12, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Telefonica Czech Republic A.S. GDR
Fiscal year is January-December. All values CZK millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 59.89B 55.71B 52.39B 50.53B 47.9B
Cost of Goods Sold (COGS) incl. D&A 24.58B 32.39B 31.81B 31.12B 40.04B
COGS excluding D&A 12.58B 20.54B 20.16B 19.68B 29.01B
Depreciation & Amortization Expense 12B 11.86B 11.65B 11.44B 11.03B
Depreciation 9.98B 9.47B 9.24B 9.15B 8.55B
Amortization of Intangibles 2.02B 2.38B 2.41B 2.28B 2.49B
Gross Income 35.31B 23.32B 20.57B 19.41B 7.86B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 11.31B 10.73B 11.28B -
Research & Development - - 0 - -
Other SG&A - 11.31B 10.73B 11.28B 900M
Other Operating Expense 20.63B 472M 0 0 0
Unusual Expense (48M) (3.72B) 10M 383M 253M
EBIT after Unusual Expense 48M 3.72B (10M) (383M) (253M)
Non Operating Income/Expense 249M 221M 278M 478M 726M
Non-Operating Interest Income 167M 80M 117M 82M 12M
Equity in Affiliates (Pretax) - 0 0 0 -
Interest Expense 263M 240M 224M 160M 67M
Gross Interest Expense 263M 240M 224M 160M 67M
Interest Capitalized 0 0 0 0 0
Pretax Income 14.88B 15.32B 10.01B 8.16B 7.27B
Income Tax 3.21B 3.04B 1.32B 1.38B 1.57B
Income Tax - Current Domestic 3.18B 2.44B 2.23B 1.86B 1.73B
Income Tax - Current Foreign 0 - 0 0 -
Income Tax - Deferred Domestic 33M 598M (907M) (477M) (163M)
Income Tax - Deferred Foreign 0 - 0 0 -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 (6M)
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 11.67B 12.28B 8.68B 6.78B 5.7B
Minority Interest Expense 0 0 0 0 0
Net Income 11.67B 12.28B 8.68B 6.78B 5.7B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 11.67B 12.28B 8.68B 6.78B 5.7B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 11.67B 12.28B 8.68B 6.78B 5.7B
EPS (Basic) 36.00 38.00 27.00 21.00 18.00
Basic Shares Outstanding 322.09M 322.09M 322.09M 319.93M 312.83M
EPS (Diluted) - 38.00 27.00 21.00 18.00
Diluted Shares Outstanding - 322.09M 322.09M 319.93M 312.83M
EBITDA 26.68B 23.39B 21.5B 19.58B 17.99B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...
Continue Reading
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Top 5 Most Recently Viewed Articles
U.S. GoldMining Champions Alaska's Development Efforts U.S. GoldMining Inc. (NASDAQ: USGO) expresses strong support for Alaska's recent push to enhance its critical road infrastructure. This initiative, led by the Alaska Industrial Development and Export Authority (AIDEA), is set to significantly improve access to the Whistler Gold-Copper Project. The proposed West...
Continue Reading
New StorageMart Facility Unveiled in Brighton StorageMart, a distinguished name in the self-storage industry, has recently opened a new facility on Wellington Road in Brighton. This latest development marks an exciting chapter of revitalization, successfully blending the site's historic charm with contemporary storage solutions that the community can rely on. A Tribute to...
Continue Reading
374Water Welcomes New Investor Relations Leader 374Water Inc. has made a significant strategic move by appointing Jim Siccardi as the Senior Vice President of Investor Relations. With an impressive background in enhancing shareholder value and building robust investor relations strategies, Siccardi is expected to boost the company's communication strategies within capital...
Continue Reading
BOC Aviation Expands Fleet with 50 Boeing 737-8 Aircraft BOC Aviation has recently enhanced its fleet by placing a firm order for 50 Boeing 737-8 jets, significantly boosting its existing portfolio. This latest acquisition expands the company's 737 MAX collection to a total of 215 aircraft, which includes both 737-8s and 737-9s. With this order, BOC Aviation will have a...
Continue Reading
Bluebird Bio's Stock Hits Record Low: A Closer Look Bluebird bio Inc has recently experienced a dramatic downturn in its stock performance, plummeting to a noteworthy 52-week low of $0.46. This decline represents a staggering reduction of approximately 84.68% over the course of a year, revealing the mounting difficulties the biotech company is grappling with. Investor...
Continue Reading